Table 1.
General characteristics of the population enrolled.
| Author | Study type | Country | CAD, N (% male) | Non CAD, N (% male) | Mean age (years) | BMI (kg/m2) | TC mmol/L [mg/dl] | C-HDL mmol/L [mg/dl] | TG mmol/L [mg/dl] | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CAD | Non-CAD | CAD | Non-CAD | CAD | Non-CAD | CAD | Non-CAD | CAD | Non-CAD | |||||
| Sun et al. [9] | Case-control | China | 130 (50) | 47 (53) | 67.0 ± 11.0 | 65.6 ± 11.0 | 21.3 ± 2.1 | 20.4 ± 14 | 4.54 ± 1.28 | 4.55 ± 0.9 | 1.15 ± 0.33 | 1.28 ± 0.31 | 1.45 ± 0.81 | 1.32 ± 0.68 |
|
| ||||||||||||||
| Fridman et al. [13] | Case-control | Argentina | 286 (37) | 245 (34) | 63.4 ± 1.5 | 60.0 ± 1.3 | NR | 5.18 ± 0.15 | 5.10 ± 0.08 | 1.58 ± 0.03 | 1.65 ± 0.03∗ | 2.00 ± 0.16 | 1.62 ± 0.09∗ | |
|
| ||||||||||||||
| Jayakumari et al. [24] | Case-control | India | 284 (100) | 245 (100) | 51.0 ± 6.9 | 44.0 ± 10.2 | NR | [206 ± 42] | [220 ± 44] | [33 ± 7.7] | [42 ± 9.5] | [164 ± 72] | [141 ± 68]∗ | |
|
| ||||||||||||||
| Mohamed et al. −[25] | Retrospective cohort | Egypt | 150 (79) | 50 (52) | 55.5 ± 8.1 | 50.7 ± 9.5 | NR | [240.5 ± 27.4] | [185.9 ± 8.4]∗ | [42.1 ± 4.2] | [54.7 ± 3.2]∗ | [175.7 ± 13.9] | [132.0 ± 14.4]∗ | |
|
| ||||||||||||||
| Shekhanawa et al. [26] | Cross-sectional | India | 60 (67) | 50 (58) | NR | NR | NR | NR | [222.6 ± 49.5] | [154 ± 32.7] | NR | NR | [206.157.6] | [123.0 ± 32.6] |
|
| ||||||||||||||
| Shen et al. [27] | Cross-sectional | China | 144 (75) | 69 (54) | 64.8 ± 10.3 | 65.3 ± 9.1 | 25.5 ± 3.4 | 24.9 ± 3.1 | 4.3 ± 1.2 | 4.4 ± 1.0 | 1.01 ± 0.24 | 1.13 ± 0.22 | 1.82 ± 1.09 | 1.75 ± 0.96 |
|
| ||||||||||||||
| Kuchta et al. [28] | Cross-sectional | Poland | 105 (39) | 45 (44) | 65 ± 10 | 63 ± 10 | 28 ± 5 | 27 ± 4 | [168 ± 41] | [196 ± 40] | [44 ± 11] | [52 ± 13] | 107 (SD NR) | 102 (SD NR) |
|
| ||||||||||||||
| Januszek et al. [29] | Case-control | Poland | 53 (100) | 53 (100) | 51.3 ± 7.8 | 42.03 ± 4.82∗∗ | 29.4 ± 4.9 | 29.2 ± 3.8 | 6.02 ± 0.81 | 5.81 ± 0.95∗ | 1.29 ± 0.34 | 1.32 ± 0.41 | 2.11 ± 1.05 | 2.01 ± 1.42 |
|
| ||||||||||||||
| Sun et al. [9] | Case-control | China | 123 (63) | 63 (44) | 69.7 ± 11.3 | 62.7 ± 10.7∗ | NR | NR | 4.08 ± 1.07 | 4.50 ± 0.99∗ | 1.06 ± 0.32 | 1.14 ± 0.27∗ | 1.56 ± 0.38 | 1.69 ± 1.27 |
|
| ||||||||||||||
| Variji et al. [30] | Case-control | Iran | 126 (66) | 203 (52) | 63.4 ± 1.5 | 60.0 ± 1.3 | NR | NR | 5.18 ± 0.15 | 5.10 ± 0.08 | 1.52 ± 0.03 | 1.65 ± 0.03∗ | 2.00 ± 0.16 | 1.62 ± 0.09∗ |
|
| ||||||||||||||
| van Himbergen et al. [14] | Case-cohort | Netherlands | 211 (NR) | 1527 (NR) | 61 ± 6 | 57 ± 5∗∗ | 26.8 ± 3.9 | 25.8 ± 3.1∗∗ | NR | NR | 1.4 ± 0.3 | 1.6 ± 0.4∗∗ | NR | NR |
|
| ||||||||||||||
| Lu et al. [15] | Case-control | |||||||||||||
|
| ||||||||||||||
| No DM cohort | - | China | 88 (66) | 90 (57) | 55.6 ± 13.8 | 57.3 ± 8.6 | NR | NR | 4.85 ± 1.22 | 4.42 ± 1.21∗ | 1.19 ± 0.29 | 1.41 ± 0.38∗ | 1.90 ± 0.92 | 1.78 ± 1.01 |
|
| ||||||||||||||
| IFG cohort | - | China | 62 (100) | 90 (57) | 57.7 ± 11.4 | 57.3 ± 8.6 | NR | NR | 5.26 ± 1.25 | 4.42 ± 1.21∗ | 1.15 ± 0.35 | 1.41 ± 0.38∗ | 2.07 ± 0.99 | 1.78 ± 1.01 |
|
| ||||||||||||||
| DM cohort | - | China | 46 (57) | 90 (57) | 60.9 ± 11.5 | 57.3 ± 8.6 | NR | NR | 5.76 ± 2.11 | 4.42 ± 1.21∗ | 1.10 ± 0.1 | 1.41 ± 0.38∗ | 2.26 ± 1.23 | 1.78 ± 1.01 |
|
| ||||||||||||||
| Ferrè et al. [16] | Case-control | Spain | 215 (100) | 215 (100) | 60.6 ± 11.8 | 62.1 ± 16.4 | 27.1 ± 4.2 | 26.2 ± 3.5 | 5.74 ± 1.10∗ | 5.27 ± 1.2∗ | 1.11 ± 0.35 | 1.23 ± 0.42∗ | 1.97 ± 1.12 | 1.52 ± 0.91∗ |
|
| ||||||||||||||
| Wang et al. [17] | Case-control | China | 474 (100) | 475 (100) | 54.1 ± 8.9 | 53.8 ± 10.2 | 26.6 ± 2.9 | 24.2 ± 3.1 | 5.16 ± 1007 | 5.06 ± 0.94 | 1.06 ± 0.23 | 1.24 ± 0.30∗ | 1.73 ± 1.13 | 1.46 ± 1.0 |
|
| ||||||||||||||
| Kerkeni et al. [18] | Case-control | Spain | 100 (74) | 120 (73) | 59 ± 10 | 54 ± 10 | 28 ± 5 | 27.6 ± 5 | 4.94 ± 1.11 | 4.20 ± 1.03∗∗ | 0.73 ± 0.13 | 0.90 ± 0.24∗∗ | 1.49 ± 1.18 | 1.19 ± 0.68 |
|
| ||||||||||||||
| Rodríguez-Esparragón et al. [19] | Case-control | Spain | 304 (78) | 315 (74) | 56 ± 10 | 54.5 ± 16 | 27.2 ± 3.7 | 27.3 ± 3.8 | 5.2 ± 1.1 | 6.1 ± 1.0∗∗ | 0.92 ± 0.24 | 1.3 ± 0.32∗∗ | 1.24 ± 0.67 | 1.52 ± 0.7∗ |
|
| ||||||||||||||
| James et al. [20] | Cross-sectional | Swiss | 137 (76) | 273 (64) | 62.8 ± 9.6 | 59.0 ± 0.5∗∗ | 27.5 ± 4.1 | 27.9 ± 4.6 | 6.0 ± 1.1 | 5.9 ± 1.1 | 1.18 ± 0.6 | 1.3 ± 0.48 | 1.85 ± 0.9 | 1.7 ± 1.1 |
| Itahara et al. [21] | Case-control | Japan | 96 (59) | 136 (52) | 65 ± 11 | 63 ± 6 | 21.0 ± 31 | 22.7 ± 2.7∗∗ | [146 ± 36] | [208±32]∗∗ | [∗∗] | [60±14]∗∗ | [106 ± 13] | [116 ± 64] |
|
| ||||||||||||||
| Rahmani et al. [22] | Cross-sectional | Iran | ||||||||||||
| DM cohort | — | 89 (57) | 73 (52) | 56 ± 7.5 | 54.6 ± 7.7 | 27.3 ± 3.5 | 27.1 ± 4.3 | [213 ± 38] | [196 ± 45]∗ | [48 ± 13] | [51 ± 13] | [209 ± 187] | [150 ± 163] | |
| No DM cohort | — | 89 (57) | 73 (52) | 56.7 ± 7.0 | 54.6 ± 7.7 | 25.9 ± 4.0 | 27.1 ± 4.3∗ | [205 ± 44] | [196 ± 45] | [48 ± 15] | [52 ± 13] | [173 ± 137] | [150 ± 163] | |
|
| ||||||||||||||
| Suehiro et al. [23] | Case-control | Japan | 81 (62) | 103 (52) | 64 ± 11 | 63 ± 11 | 21.2 ± 3.0 | 22.5 ± 2.0∗ | [149 ± 38] | [206 ± 31]∗ | [40 ± 13] | [58±13]∗∗ | [106 ± +60] | [115±67]∗∗ |
CAD: coronary artery disease; BMI: body mass index; TC: total cholesterol; HDL: high-density lipoproteins; TG: triglycerides; DM: diabetes mellitus; IFG: impaired fasting glucose. The lipidic profile is presented with the measure's unit used in the original manuscript. ∗p < 0.05 vs controls; ∗∗p < 0.0001 vs. controls.